Related Experiment Video

Updated: Jun 5, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.2K

Regulation of ovarian cancer by protein post-translational modifications

Qiugang Zhu1, Huimin Zhou2, Feiting Xie3

  • 1Department of Laboratory Medicine, Shangyu People's Hospital of Shaoxing, Shaoxing University, Shaoxing, China.

Frontiers in Oncology
|December 16, 2024
PubMed

Insights

Post-translational modifications (PTMs) are crucial in ovarian cancer development, affecting cell cycle, metabolism, and immune response. Targeting these protein alterations offers promising therapeutic strategies for this common gynecologic malignancy.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Ovarian cancer is a leading cause of death among women globally.
  • Post-translational modifications (PTMs) alter protein function and are implicated in various diseases.
  • PTMs are increasingly recognized for their roles in ovarian cancer pathogenesis.

Purpose of the Study:

  • To review the latest advancements in understanding protein PTMs in ovarian cancer.
  • To explore the multifaceted roles of PTMs in ovarian cancer progression.
  • To introduce therapeutic strategies targeting PTMs in ovarian cancer.

Main Methods:

  • Literature review of recent studies on PTMs in ovarian cancer.
  • Analysis of PTMs' influence on key cancer processes.
  • Discussion of pharmacological approaches targeting PTMs.

Main Results:

  • PTMs significantly impact cell cycle regulation, metabolic reprogramming, chemoresistance, and anti-tumor immunity in ovarian cancer.
  • Diverse PTMs contribute to the complex molecular mechanisms driving ovarian cancer.
  • Targeting PTMs presents a viable therapeutic avenue.

Conclusions:

  • A deep understanding of PTMs is essential for deciphering ovarian cancer's molecular intricacies.
  • Pharmacological targeting of PTMs holds potential for novel ovarian cancer treatments.
  • Further research into PTMs can lead to improved patient outcomes.
Keywords:
molecular mechanismsovarian cancerpathogenesispost-translational modificationstherapeutic strategies

More Related Videos

Transplantation Into the Mouse Ovarian Fat Pad09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

11.3K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K

Related Concept Videos

Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
869
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
22.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
What is Gene Expression?01:36

What is Gene Expression?

A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then...
8.4K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K